We are live on
!
Find out more
CCM
Catapult Capital Management Portfolio holdings
AUM
$265M
1-Year Est. Return
21.83%
This Fund
S&P 500
This Quarter
Est. Return
-6.98%
1 Year Est. Return
+21.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$265M
AUM Growth
-$431M
(-62%)
Cap. Flow
-$403M
Cap. Flow
% of AUM
-152.44%
Top 10 Holdings %
Top 10 Hldgs %
27.43%
Holding
286
New
68
Increased
19
Reduced
60
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$9.98M |
| 2 |
NUVA
NuVasive, Inc.
NUVA
|
+$4.39M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$3.85M |
| 4 |
Boston Scientific
BSX
|
+$3.16M |
| 5 |
Pfizer
PFE
|
+$3.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$16M |
| 2 |
AbbVie
ABBV
|
+$15.9M |
| 3 |
Zoetis
ZTS
|
+$13.5M |
| 4 |
PepsiCo
PEP
|
+$12.8M |
| 5 |
McKesson
MCK
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.36% |
| 2 | Consumer Discretionary | 7.36% |
| 3 | Industrials | 6.49% |
| 4 | Technology | 4.09% |
| 5 | Financials | 3.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Bio-Rad Laboratories Class A
BIO
$8.74B
| $1.65M | 0.62% |
12,280
-9,294
| -43% | -$1.34M |
|
|
OMG
52
PUT
DELISTED
OM GROUP INC.
OMG
| $1.65M | 0.62% |
+50,000
| New | +$1.68M |
|
53
Leidos
LDOS
$14.1B
| $1.63M | 0.62% |
+39,394
| New | +$1.64M |
|
54
Labcorp
LH
$25.9B
| $1.63M | 0.62% |
+17,460
| New | +$1.81M |
|
55
GSK
GSK
$104B
| $1.62M | 0.61% |
+33,629
| New | +$1.75M |
|
56
Crown Holdings
CCK
$12.9B
| $1.61M | 0.61% |
35,233
-6,029
| -15% | -$305K |
|
57
CALL
Yum! Brands
YUM
$43.3B
| $1.6M | 0.6% |
+27,820
| New | +$1.68M |
|
|
VSI
58
DELISTED
Vitamin Shoppe Inc.
VSI
| $1.6M | 0.6% |
+48,964
| New | +$1.75M |
|
59
Alphabet (Google) Class C
GOOG
$4.08T
| $1.54M | 0.58% |
48,180
-3,980
| -8% | -$122K |
|
60
Textron
TXT
$15B
| $1.51M | 0.57% |
40,229
-3,496
| -8% | -$145K |
|
61
Weyerhaeuser
WY
$16.9B
| $1.51M | 0.57% |
55,309
-56,030
| -50% | -$1.65M |
|
62
PUT
Intel
INTC
$460B
| $1.51M | 0.57% |
+50,000
| New | +$1.45M |
|
63
Mohawk Industries
MHK
$7.29B
| $1.51M | 0.57% |
8,284
-15,394
| -65% | -$3.05M |
|
|
ESL
64
DELISTED
Esterline Technologies
ESL
| $1.51M | 0.57% |
20,946
-1,739
| -8% | -$148K |
|
|
TIF
65
DELISTED
Tiffany & Co.
TIF
| $1.5M | 0.57% |
19,361
-13,409
| -41% | -$1.17M |
|
66
CALL
Carpenter Technology
CRS
$25B
| $1.49M | 0.56% |
+50,000
| New | +$1.82M |
|
67
Republic Services
RSG
$65B
| $1.47M | 0.56% |
+35,691
| New | +$1.47M |
|
68
Teva Pharmaceuticals
TEVA
$41.2B
| $1.47M | 0.55% |
25,954
-76,877
| -75% | -$4.98M |
|
69
Amazon
AMZN
$2.53T
| $1.46M | 0.55% |
57,020
-110,420
| -66% | -$2.79M |
|
70
CALL
H&R Block
HRB
$5.61B
| $1.45M | 0.55% |
40,000
+15,000
| +60% | +$508K |
|
71
Xylem
XYL
$27.3B
| $1.4M | 0.53% |
42,678
-55,959
| -57% | -$1.88M |
|
|
CAB
72
DELISTED
Cabela's Inc
CAB
| $1.4M | 0.53% |
+30,621
| New | +$1.43M |
|
73
Bristol-Myers Squibb
BMY
$132B
| $1.39M | 0.53% |
+23,542
| New | +$1.49M |
|
|
74
AbbVie
ABBV
$455B
| $1.37M | 0.52% |
25,214
-244,786
| -91% | -$15.9M |
|
75
Canadian Pacific Kansas City
CP
$78.3B
| $1.36M | 0.51% |
47,385
-14,235
| -23% | -$429K |
|
Similar funds
LOCB
AF
TCOTO
DCM
SCA
LPVHS
ATC
TFF
Catapult Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Catapult Capital Management held 286 positions worth $265M, down 62% from $696M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Catapult Capital Management withdrew a net $403M in Q3 2015, closing 135 positions and reducing 60 holdings. Its most notable exit was PepsiCo, an estimated $12.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 43% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Catapult Capital Management opened a new position in Vertex Pharmaceuticals worth $3.12M.
- Catapult Capital Management's largest Q3 2015 buy was Vertex Pharmaceuticals: 30,000 shares worth $3.12M.
- Catapult Capital Management added most to Allergan plc in Q3 2015, an estimated $9.98M increase.
- Catapult Capital Management's biggest Q3 2015 reduction was CVS Health, cutting an estimated $16M.
- Catapult Capital Management fully exited PepsiCo in Q3 2015, selling an estimated $12.8M.
- Catapult Capital Management's ten largest holdings make up 27% of its $265M portfolio in Q3 2015.
- Catapult Capital Management opened 68 new positions and closed 135 in Q3 2015.
- Catapult Capital Management's portfolio value fell 62% quarter-over-quarter to $265M.
Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.